Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis#
, , , , , , , , , , , , und | 10. Juli 2018
Über diesen Artikel
Article Category: review
Online veröffentlicht: 10. Juli 2018
Seitenbereich: 52 - 71
DOI: https://doi.org/10.21307/sjcapp-2018-003
Schlüsselwörter
© 2018 Erica Ramstad et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Erica Ramstad
Psychiatric Research UnitRegion Zealand, Denmark
Child and Adolescent Psychiatric DepartmentRegion Zealand, Denmark
Ole Jakob Storebø
Child and Adolescent Psychiatric DepartmentRegion Zealand, Denmark
Department of Psychology, Faculty of Health Science, University of Southern DenmarkOdense, Denmark
Trine Gerner
Psychiatric Research UnitRegion Zealand, Denmark
Helle B. Krogh
Psychiatric Research UnitRegion Zealand, Denmark
Child and Adolescent Psychiatric DepartmentRegion Zealand, Denmark
Mathilde Holmskov
Psychiatric Research UnitRegion Zealand, Denmark
Frederik L. Magnusson
Psychiatric Research UnitRegion Zealand, Denmark
Carlos R. Moreira-Maia
Federal University of Rio Grande do SulPorto Alegre, Brazil
Maria Skoog
Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University HospitalCopenhagen, Denmark
Camilla Groth
Pediatric Department E, Herlev University HospitalHerlev, Denmark
Donna Gillies
Western Sydney Local Health District; Mental HealthParramatta, Australia
Morris Zwi
Islington CAMHS, Whittington HealthWhittington, United-states
Richard Kirubakaran
Cochrane South Asia, Prof. BV Moses Center for Evidence-Informed Health Care and Health Policy, Christian Medical CollegeVellore, India
Christian Gluud
Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University HospitalCopenhagen, Denmark
The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University HospitalCopenhagen, Denmark
Erik Simonsen
Psychiatric Research UnitRegion Zealand, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of CopenhagenCopenhagen, Denmark